|
|
 | | | |
- close
- close
- close
- close
Amex Pharmaceutical Index (DRG) |
The Times of India
May 16
Comment
Cash rich Ajay Piramal, chairman of Piramal Healthcare, clinched a third acquisition after selling formulations business to Abbott Laboratories for $3.8 billion two years ago. The ace deal maker has agreed to acquire US healthcare data research...
Mining Weekly
Feb 13
Comment
ASX- and TSX-listed Anvil Mining has cleared the way for a takeover by Minmetals Resources, after gaining Minmetals shareholder approval and reaching an agreement with its Democratic Republic of Congo (DRG) stakeholder.
Minmetals was offering C$8...
The Analytic
Oct 13
Comment
BANGKOK, 13 October 2011 -The Transport Company is urging travelers to allow themselves some times to plan their trip in advance if they are going to the North or Northeast as many roads are still submerged.
The Public Relations Section of the...
The Analytic
Oct 13
Comment
BANGKOK, 13 October 2011 -The Public Relations Section of the DRG Center for Flood Victims has recently revealed that flood evacuees have continued to arrive at the temporary shelter provided by Thammasart University, Rangsit campus this morning....
The Analytic
Oct 13
Comment
BANGKOK, 13 October 2011 -The Spokesperson of the DRG Center for Flood Victims, Mr. Wim Rungwattanajinda, revealed at the press conference this morning that the flood water had now inundated the low-lying areas of Pathum Thani and Nonthaburi...
MarketWatch
Aug 2
Comment
Drug stocks continued to slide into the red midday Tuesday after the U.S. Senate voted for a bill that would raise the debt-borrowing ceiling for the U.S. government. The bill, which was passed by the House late Monday, next moves to President...
MarketWatch
Jul 27
Comment
Nabi Biopharmaceuticals is biotech’s latest stock casualty, and analysts warn not to expect a rebound any time soon.
MarketWatch
Apr 27
Comment
Drug stocks gained ground Wednesday afternoon following an announcement by the Federal Reserve that it plans to keep its key interest rates in a target range of 0% to 0.25% and to end its $600 billion bond-buying program on June 30, as previously...
MarketWatch
Apr 15
Comment
Merck and Amylin are the advancers of note among the larger-cap drug stocks in afternoon trading Friday.
MarketWatch
Apr 14
Comment
Idenix and InterMune are the advancers of note in afternoon trading of drug stocks Thursday.
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
| |||||||
